Senomyx Names VP of Discovery
Karanewsky received his Ph.D. in Chemistry from Harvard University and was granted a B.S. in Chemistry, Magna Cum Laude, from Stevens Institute of Technology in New Jersey. He has directed chemistry research teams and played senior management roles at a number of biotechnology institutions including Idun Pharmaceuticals, Ligand Pharmaceuticals and most recently, The Genomics Institute of the Novartis Research Foundation (GNF). In addition, he held principal positions at Glaxo Inc., Bristol-Myers Squibb, and the Squibb Institute for Medical Research. Karanewsky is an inventor on more than 70 issued U.S. patents and has authored over 50 scientific publications.
"We are extremely fortunate to have someone of Don's caliber and experience joining Senomyx," said Mark J. Zoller, Ph.D., executive vice president of Discovery and Development and chief scientific officer at the company. "His areas of expertise include the generation of chemical libraries and the use of receptor-based assays for the identification and optimization of new compounds, which are important aspects of Senomyx's discovery efforts. Along with the recent addition of Albert Zlotnik, Ph.D., as vice president, Biology, we have now filled our key scientific management positions. We look forward to having these highly regarded scientists direct our outstanding Biology and Discovery teams to further Senomyx's position as a leader in the science of human taste."
Senomyx's scientific capabilities have been further validated with Nestle's initial commercialization of products containing new flavor ingredients that were discovered and developed in-house by Senomyx using our proprietary technologies," stated Kent Snyder, president and chief executive officer of the company. "This is an exciting time for Senomyx, and we welcome Don's input as we work to create new flavor ingredients that meet the needs of our seven world-class food and beverage company partners."
From the June 18, 2007, Prepared Foods e-Flash